← FDA Drug Approvals (Drugs@FDA)

PITAVASTATIN CALCIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2023-02-22

Drug application

FDA Application #

ANDA206047

Application type

Abbreviated New Drug Application (Generic)

Brand name

PITAVASTATIN CALCIUM

Generic name

PITAVASTATIN CALCIUM

Active ingredients

PITAVASTATIN CALCIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ZYDUS PHARMS

Manufacturer

Zydus Lifesciences Limited

First approval

2023-02-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown